DOMINICI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.999
EU - Europa 17.995
AS - Asia 16.024
SA - Sud America 2.539
AF - Africa 304
OC - Oceania 83
Continente sconosciuto - Info sul continente non disponibili 27
Totale 73.971
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.385
IT - Italia 5.143
CN - Cina 5.106
SG - Singapore 4.818
GB - Regno Unito 4.817
HK - Hong Kong 2.380
BR - Brasile 2.017
DE - Germania 1.802
SE - Svezia 1.664
VN - Vietnam 1.055
RU - Federazione Russa 904
FI - Finlandia 580
TR - Turchia 575
UA - Ucraina 565
IE - Irlanda 516
ID - Indonesia 438
KR - Corea 421
FR - Francia 406
CA - Canada 360
IN - India 308
BG - Bulgaria 280
NL - Olanda 256
JP - Giappone 230
AR - Argentina 216
MX - Messico 178
BE - Belgio 160
PL - Polonia 147
ES - Italia 144
ZA - Sudafrica 126
AT - Austria 117
BD - Bangladesh 97
LT - Lituania 85
AU - Australia 77
CZ - Repubblica Ceca 71
RO - Romania 71
EC - Ecuador 67
PK - Pakistan 60
IR - Iran 58
IQ - Iraq 56
MY - Malesia 50
CO - Colombia 48
CH - Svizzera 46
VE - Venezuela 46
TW - Taiwan 45
CL - Cile 44
AE - Emirati Arabi Uniti 40
AL - Albania 39
MA - Marocco 37
NO - Norvegia 37
IL - Israele 35
PY - Paraguay 33
PE - Perù 32
EG - Egitto 31
KE - Kenya 29
UZ - Uzbekistan 29
SA - Arabia Saudita 26
PH - Filippine 22
PT - Portogallo 20
DZ - Algeria 19
UY - Uruguay 19
JO - Giordania 18
EU - Europa 16
GR - Grecia 15
RS - Serbia 15
TH - Thailandia 15
AZ - Azerbaigian 14
SI - Slovenia 14
DK - Danimarca 13
DO - Repubblica Dominicana 13
KZ - Kazakistan 13
LB - Libano 13
NP - Nepal 12
OM - Oman 12
BO - Bolivia 11
BZ - Belize 11
TN - Tunisia 11
CR - Costa Rica 9
MD - Moldavia 9
PA - Panama 9
AM - Armenia 8
HR - Croazia 8
JM - Giamaica 8
EE - Estonia 7
GE - Georgia 7
HU - Ungheria 7
KG - Kirghizistan 7
SY - Repubblica araba siriana 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BY - Bielorussia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
LV - Lettonia 6
MK - Macedonia 6
MT - Malta 6
NG - Nigeria 6
AO - Angola 5
KH - Cambogia 5
LK - Sri Lanka 5
MN - Mongolia 5
SN - Senegal 5
Totale 73.858
Salva come PNG Salva come JPEG
Città #
Fairfield 3.780
Santa Clara 3.682
Ashburn 3.546
Singapore 3.142
Southend 2.741
Hong Kong 2.330
Chandler 2.282
Woodbridge 1.977
Hefei 1.792
Houston 1.581
Seattle 1.360
Wilmington 1.200
Cambridge 1.173
Ann Arbor 1.113
London 1.035
Nyköping 979
Jacksonville 971
Dearborn 859
Beijing 808
Los Angeles 803
Chicago 787
Modena 640
New York 588
Munich 522
Dallas 505
Dublin 484
Bologna 439
San Diego 425
Seoul 389
Ho Chi Minh City 388
Milan 361
Jakarta 353
Helsinki 318
Izmir 309
Princeton 306
Salt Lake City 290
Moscow 284
Sofia 277
Shanghai 268
The Dalles 244
Hanoi 236
Buffalo 213
Eugene 200
Council Bluffs 199
São Paulo 186
Rome 169
Tokyo 162
Frankfurt am Main 157
Elk Grove Village 148
Parma 148
Tampa 146
Boardman 132
Reggio Emilia 132
Redwood City 130
Phoenix 128
Des Moines 121
Brussels 120
Falls Church 119
Bremen 114
Nuremberg 114
Columbus 110
Mcallen 109
Warsaw 109
Fremont 107
Montréal 103
Guangzhou 102
Lancaster 94
Denver 87
Kent 87
Brooklyn 84
Atlanta 83
Montreal 78
Johannesburg 77
Rio de Janeiro 77
Redondo Beach 76
Orem 73
Sterling 70
Toronto 70
Mexico City 69
Amsterdam 68
Lauterbourg 65
Turku 64
Stockholm 63
Portsmouth 61
Dong Ket 60
Manchester 60
Poplar 60
Vienna 60
Chennai 59
Miami 57
Grafing 56
Norwalk 56
Florence 50
San Francisco 48
Verona 48
Brno 47
San Giuliano Milanese 46
Lappeenranta 45
Naples 45
Boston 43
Totale 51.231
Salva come PNG Salva come JPEG
Nome #
Dynamic cultivation of mesenchymal stem cell aggregates 627
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies 515
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 463
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 428
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 423
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 422
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 385
Rigenerand srl - Spin off Università di Modena e Reggio Emilia 381
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 381
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 379
GD2 expression in breast cancer. 379
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 376
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 371
Autologous Porcine Bone Marrow Mesenchymal Cells for Reconstruction of a Resorbed Alveolar Bone: A Preclinical Model in Mini-Pigs 366
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 360
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 353
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 351
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns 349
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 348
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 347
Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche 344
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells 338
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 330
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells 329
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 328
A novel function for amniotic fluid: original or authentic? 327
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 327
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 326
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 325
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 322
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 317
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 315
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 313
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 308
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 308
An alternative approach to investigate biofilm in medical devices: A feasibility study 308
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 304
In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids 303
Clarification of the nomenclature for MSC: the international society for cellular therapy position statement 302
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 301
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 301
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 300
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 299
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 297
Phase I study of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with peritoneal carcinosis 297
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 297
Tumor Stroma Manipulation By MSC 296
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 294
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 292
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 290
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 289
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 288
Potency biomarker signature genes from multiparametric osteogenesis assays: Will cGMP human bone marrow mesenchymal stromal cells make bone? 288
Human mesenchymal stem cell combined with a new strontium-enriched bioactive glass: An ex-vivo model for Bone Regeneration 288
How do mesenchymal stromal cells exert their therapeutic benefit? 286
Transgenic Mice with Pancellular Enhanced Green Fluorescent Protein Expression in Primitive Hematopoietic Cells and All Blood Cell Progeny 285
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 285
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche 282
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 279
Cytokine-Induced Osteopoietic Differentiation of Transplanted Marrow Cells 277
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 277
Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of mice 275
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons 273
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 273
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 272
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 271
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 271
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 269
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 267
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, Germany 266
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 265
Bone marrow mesenchymal cells: biological properties and clinical applications. 263
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 263
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. 262
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 262
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 261
GD2 CAR T cells against human glioblastoma 261
Cell therapy for disorders of bone 258
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial 256
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 254
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 254
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes. 254
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 253
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 253
Cell therapies for pancreatic beta-cell replenishment. 252
Getting beneath the skin to understand MSC complexity 252
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 251
A new bioactive glass with extremely high crystallization temperature and outstanding biological performance 249
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST 247
Detection of microparticles from human red blood cells by multiparametric flow cytometry 246
Identification of a murine CD45-F4/80lo HSC-derived marrow endosteal cell associated with donor stem cell engraftment 246
A new Approach to Investigate Biofilm Formation in Medical Devices 243
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 243
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 243
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 242
Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation 242
International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials 242
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 238
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 238
An adoptive immuno-gene therapy approach targeting neuroblastoma. 237
Totale 30.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 312.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 312.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.433 0 0 0 0 0 638 478 734 469 890 792 432
2021/20226.659 365 738 581 348 284 474 400 410 653 525 1.072 809
2022/20237.308 824 784 544 663 742 907 191 654 1.160 136 404 299
2023/20245.124 257 309 365 495 823 502 513 600 154 196 287 623
2024/202516.829 497 226 488 1.146 2.697 2.488 1.410 981 1.964 1.134 1.625 2.173
2025/202617.909 2.334 1.402 3.053 4.292 5.756 1.072 0 0 0 0 0 0
Totale 74.712